Published in J Urol on February 01, 2007
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med (2009) 6.61
Cancer linked to Alzheimer disease but not vascular dementia. Neurology (2009) 4.83
High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer. J Urol (2014) 2.17
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA Oncol (2015) 2.06
Health disparities in staging of SEER-medicare prostate cancer patients in the United States. Urology (2010) 1.50
Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities. Clin Cancer Res (2015) 1.46
Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol (2010) 1.26
Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men. Int J Oncol (2009) 1.13
Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis (2011) 1.10
The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study. BJU Int (2010) 1.06
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01
A review of African American-white differences in risk factors for cancer: prostate cancer. Cancer Causes Control (2010) 0.99
Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study. BMC Cancer (2009) 0.93
Current state of prostate cancer treatment in Jamaica. Ecancermedicalscience (2014) 0.89
Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy. Cancer Epidemiol Biomarkers Prev (2014) 0.87
Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer. Asian J Androl (2010) 0.86
Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2011) 0.86
Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev (2009) 0.81
Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans. Carcinogenesis (2012) 0.81
The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort. Cancer Causes Control (2014) 0.81
Outcomes after Radical Prostatectomy in Ghanaians: A Surgeon's Early Experience. ISRN Urol (2013) 0.80
Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men. Prostate Cancer Prostatic Dis (2013) 0.79
Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program. Cancer (2008) 0.79
Using focus groups to adapt ethnically appropriate, information-seeking and recruitment messages for a prostate cancer screening program for men at high risk. J Natl Med Assoc (2008) 0.79
Variation in HNF1B and Obesity May Influence Prostate Cancer Risk in African American Men: A Pilot Study. Prostate Cancer (2013) 0.78
Racial variation in the cost-effectiveness of chemotherapy for prostate cancer. J Oncol Pract (2011) 0.78
Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer. Int J Cancer (2016) 0.78
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments. Onco Targets Ther (2011) 0.78
Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China. Oncotarget (2015) 0.77
Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history. Prostate Cancer Prostatic Dis (2008) 0.77
Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat Commun (2017) 0.76
Is prostate cancer different in black men? Answers from 3 natural history models. Cancer (2017) 0.75
Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research. Cancer Causes Control (2013) 0.75
GPRC6A: Jack of all metabolism (or master of none). Mol Metab (2016) 0.75
Commentary: Building an Evidence Base for Promoting Informed Prostate Cancer Screening Decisions: An Overview of a Cancer Prevention and Control Program. Ethn Dis (2017) 0.75
Outcome of radical retropubic prostatectomy at the Lagos State University Teaching Hospital. Niger Med J (2016) 0.75
Cardio-Vascular Disease and Cancer: A Dichotomy in Utilization of Clinical Preventive Services by Older Adults in a Developing Country. Gerontol Geriatr Med (2015) 0.75
Immunohistological analysis of ABCD3 expression in Caucasian and African American prostate tumors. Biomed Res Int (2015) 0.75
The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study. Prostate Cancer Prostatic Dis (2017) 0.75